Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Other Operating Expenses (2018 - 2026)

Emergent BioSolutions (EBS) posted Other Operating Expenses of -$10.7 million for Q2 2026, down 187.7% on a QoQ basis from $12.2 million in Q4 2025.

Analysis

Emergent BioSolutions (EBS) Other Operating Expenses (2018 - 2026) Analysis & Trends

Emergent BioSolutions has reported Other Operating Expenses for 9 years, with the latest figure at -$10.7 million in Q2 2026.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to -$10.7 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 97.12% decrease from a year earlier, with the FY2024 full-year figure at $24.3 million, down 67.25% from the prior year.
  • Other Operating Expenses was -$10.7 million for Q2 2026 at Emergent BioSolutions, down from $12.2 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $169.9 million in Q1 2022, with the low at -$40.0 million in Q2 2024.
  • Average Other Operating Expenses over 5 years is $47.5 million, with a median of $12.2 million recorded in 2025.
  • The largest YoY upside for Other Operating Expenses was 9285.71% in 2024 against a maximum downside of 153.4% in 2024.
  • Over 5 years, Other Operating Expenses stood at $169.9 million in 2022, then slumped by 100.41% to -$700000.0 in 2023, then soared by 9285.71% to $64.3 million in 2024, then slumped by 81.03% to $12.2 million in 2025, then sank by 187.7% to -$10.7 million in 2026.
  • The last three Other Operating Expenses figures came in at -$10.7 million (Q2 2026), $12.2 million (Q4 2025), and -$12.2 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn
9 Revolution Medicines 41.30 Bn 41.30 Bn -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.70 Mn
Dec 31, 2025 12.20 Mn
Mar 31, 2025 -12.20 Mn
Sep 30, 2024 64.30 Mn
Jun 30, 2024 -40.00 Mn
Sep 30, 2023 -700,000.00
Jun 30, 2023 74.90 Mn
Mar 31, 2023 169.90 Mn
Mar 31, 2022 169.90 Mn
Dec 31, 2021 305.20 Mn
Sep 30, 2021 232.00 Mn
Jun 30, 2021 242.90 Mn
Mar 31, 2021 114.20 Mn
Dec 31, 2020 196.30 Mn
Sep 30, 2020 164.00 Mn
Jun 30, 2020 144.80 Mn
Mar 31, 2020 91.70 Mn
Dec 31, 2019 147.60 Mn
Sep 30, 2019 122.70 Mn
Jun 30, 2019 115.50 Mn
API Access

Emergent BioSolutions Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY